Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168.6 USD | +1.22% | -0.49% | +8.79% |
Jun. 14 | AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer | MT |
Jun. 13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.79% | 298B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine